Shanghai Haohai loads up $200m IPO
Shanghai Haohai Biological Technology kicked off investor education for its $200m IPO on April 8, with the issuer’s strong credentials expected to make the stock a straightforward story to understand.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts